Abstract
Type 2 diabetes is responsible for the increased prevalence of ischaemic heart disease, generally related to coronary artery disease, which is associated with increased morbidity and death in diabetic patients. Epidermal growth factor receptor (EGFR) tyrosine kinase, one of the many factors involved in cell growth and migration, has been shown to be key element in the development of microvessel myogenic tone. In a recent study, we have shown that microvascular dysfunction in type 2 diabetes is dependent on the exacerbation of the EGFR tyrosine kinase phosphorylation. Thus, further elucidation of this EGFR transactivation and down stream signalling will offer a new direction to investigate the mechanism of microvascular dysfunction responsible for heart disease that occurs in type 2 diabetes. In this review, we discuss the link between the EGFR transactivation and microvascular dysfunction that occurs in type 2 diabetes.
References
Apr 1, 1990·Physiological Reviews·J I Hoffman, J A Spaan
Jan 1, 2000·Cardiovascular Research·Z UngvariA Koller
Jul 17, 2001·American Journal of Physiology. Heart and Circulatory Physiology·G S Kassab, S Molloi
Oct 6, 2001·Diabetologia·N J MorrishH Keen
Dec 12, 2001·Journal of Vascular Research·G J LagaudG P Dubé
Dec 11, 2002·Circulation·Ian SchofieldAnthony Heagerty
Jun 14, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Zsolt BagiGabor Kaley
Jun 28, 2003·The Journal of Biological Chemistry·Atsushi Konishi, Bradford C Berk
Nov 5, 2004·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Azra Mahmud, John Feely
Nov 24, 2004·Circulation·Pamela A LucchesiKhalid Matrougui
Jun 22, 2005·Cardiovascular Research·Desiree I PalenKhalid Matrougui
Oct 19, 2005·Cancer Research·Dai ShidaHirokazu Nagawa
Aug 12, 2006·Circulation Research·Peiyong ZhaiJunichi Sadoshima
Mar 6, 2008·Diabetes·Souad BelmadaniKhalid Matrougui
Nov 1, 2008·Diabetes/metabolism Research and Reviews·Desiree I Palen, Khalid Matrougui
Nov 14, 2008·Journal of Cellular Physiology·Marlon R Schneider, Eckhard Wolf
Apr 4, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Souad BelmadaniWilliam M Chilian
Jul 7, 2009·Vascular Pharmacology·Ibrahim F BenterSaghir Akhtar
Citations
Jul 3, 2010·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Ran KleinRobert A deKemp
Aug 27, 2010·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Tali SharirDaniel S Berman
Oct 27, 2011·Cardiovascular Research·Mei FengHui Liu
Oct 18, 2013·International Journal of Molecular Sciences·Nader MakkiFrancis J Miller
Jun 27, 2015·Journal of Drug Targeting·Ibrahim F BenterSaghir Akhtar
Apr 14, 2015·Journal of Molecular and Cellular Cardiology·Zheng Xu, Lu Cai
Nov 10, 2011·The American Journal of Pathology·Soo-Kyoung ChoiKhalid Matrougui
Jul 30, 2014·Antioxidants & Redox Signaling·Raúl R Rodrigues-DiezMarta Ruiz-Ortega
Nov 5, 2015·PloS One·Saghir AkhtarIbrahim F Benter
Sep 24, 2011·Journal of Proteome Research·Jia-Peng LuWei Wang
Jan 3, 2012·Analytical Chemistry·Chung-Liang WangKuo Chu Hwang
Jan 4, 2017·The International Journal of Biochemistry & Cell Biology·Melissa E ReicheltJohn P Headrick
Jul 10, 2012·Journal of Diabetes Science and Technology·H James HarwoodJanice D Wagner
Oct 19, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carmen GalanJuan A Rosado
Apr 3, 2015·Physiological Reviews·Mattias CarlströmWilliam J Arendshorst
Dec 10, 2017·Oncotarget·Chunpeng ZouYunjie Zhao
Dec 31, 2017·Pflügers Archiv : European journal of physiology·Vishal MaliSouad Belmadani
Sep 29, 2019·Biomarkers in Medicine·Eric AduaWei Wang
Oct 18, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Steven D BrooksPaul D Chantler
Feb 13, 2021·Frontiers in Pharmacology·Lili ShengShougang Zhuang
Aug 20, 2021·Frontiers in Pharmacology·Bara A ShraimSaghir Akhtar